SLC22A3 exhibited a substantial log2 fold change of 1.935795, coupled with an exceptionally significant adjusted p-value (padj = 9.574958e-42), indicating its marked upregulation in CRC tissues compared to normal tissues. This evidence concerns the gene SLC22A3 and colorectal carcinoma.